Shandong Weigao Group Medical Polymer Company Limited
SHWGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.36 | -0.56 | 0.90 | 1.99 |
| FCF Yield | 9.65% | 6.82% | 2.25% | 3.90% |
| EV / EBITDA | 4.93 | 7.93 | 10.60 | 12.43 |
| Quality | ||||
| ROIC | 6.75% | 6.97% | 8.96% | 9.50% |
| Gross Margin | 50.28% | 50.21% | 53.64% | 55.91% |
| Cash Conversion Ratio | 1.09 | 1.18 | 0.67 | 1.07 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.32% | 0.20% | 5.43% | 8.26% |
| Free Cash Flow Growth | 1.40% | 92.37% | -42.74% | 12.77% |
| Safety | ||||
| Net Debt / EBITDA | -0.95 | -0.79 | -0.54 | -0.66 |
| Interest Coverage | 9.56 | 8.42 | 15.28 | 20.57 |
| Efficiency | ||||
| Inventory Turnover | 2.57 | 2.64 | 2.81 | 3.30 |
| Cash Conversion Cycle | 108.88 | 101.12 | 182.59 | 149.20 |